Key result
Percutaneous ventricular support devices successfully support failing left ventricles across diverse clinical settings.
Why the study?
When the heart experiences end-stage systolic ventricular failure, it is generally unable to restore practical function with pharmacological therapy alone.
This review summarizes the indications, functionality, and complications of percutaneous mechanical circulatory support devices for left ventricular failure.
May guide temporary percutaneous MCS use in LV failure; leaves open optimal device selection and outcomes in prospective trials.
This article reviews the indications, contraindications, functionality, and complications for various percutaneous devices that can be used to support the left ventricular failure. We also reviews the anesthetic effect for these devices. A literature review was performed using PubMed. When the heart experiences end-stage systolic ventricular failure, it is generally unable to restore its practical function with pharmacological therapy alone. Percutaneous ventricular support devices have been introduced and used successfully to support a failing ventricle in a variety of settings. These devices include intra-aortic balloon pump, TandemHeart, and Impeller, as well as veno-arterial extracorporeal membrane oxygenation for left ventricular support. These devices are typically accessed percutaneously through the femoral vessels and/or the jugular vein(s), although other sites are possible in unique cases.
No takes yet. Share an insight, caveat, or question.
Franklin et al. (2019) conducted a review in Left ventricular failure. Percutaneous ventricular support devices was evaluated. Percutaneous ventricular support devices, including intra-aortic balloon pump, TandemHeart, Impeller, and VA-ECMO, can successfully support a failing left ventricle in a variety of settings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: